This is consistent with our finding that monocyte subsets have decreased CD16+ associated with increased asthma severity and the suggestion that monocytes newly released from the bone marrow have not fully reduced CCR2 and acquired CX3CR1 in addition to CD16. Here, CX3CR1 is linked to asthma.